2-O-(2-Methoxyethyl)adenosine丨CAS 168427-74-5

2-O-(2-Methoxyethyl)adenosine is primarily used as a specialized nucleoside derivative in pharmaceutical research and medicinal chemistry. It serves as a versatile building block for the synthesis of modified nucleotides and nucleoside analogs, which are crucial in the development of antiviral, anticancer, and neuroprotective agents. Its unique 2-methoxyethyl modification enhances the chemical versatility of the adenosine molecule, allowing selective functionalization for incorporation into oligonucleotides and RNA mimetics used in therapeutic research. Additionally, it is applied in the study of adenosine receptor ligands and modulators, enabling detailed exploration of purinergic signaling pathways, which are important in cardiovascular, neurological, and immunological research. The compound is also utilized in enzymatic studies as a substrate or probe to evaluate nucleoside-processing enzymes, contributing to both drug discovery and biochemical investigations.

The incorporation of a 2-methoxyethyl group provides several advantages that make this adenosine derivative particularly valuable in research. It enhances the solubility and stability of the molecule compared to unmodified adenosine, which facilitates handling in chemical synthesis and biological assays. The modification also confers resistance to enzymatic degradation, allowing for more reliable experimental results in enzymology and cellular studies. Its structure permits selective interaction with specific enzyme sites or receptors, improving the precision and efficiency of biological studies. Additionally, the derivative's compatibility with a variety of chemical transformations makes it a flexible tool for designing nucleoside-based drugs or molecular probes. Researchers can exploit these properties to optimize pharmacokinetic profiles, improve target specificity, and develop nucleoside analogs with enhanced therapeutic potential.